直接面向消费者的互联网处方平台忽视年轻勃起功能障碍男性传统面诊中的关键病理
本研究回顾性分析2016年1月至2019年3月在男科门诊评估的388例≤40岁勃起功能障碍(ED)男性,发现肥胖15%、糖尿病前期或糖尿病20%、血脂异常54%、性腺功能减退20%,不育相关实验室异常11%,精液分析异常40%,精索静脉曲张35%;新闻媒体分析显示61%的文章对DTC平台持完全正面态度。结论认为DTC平台仅凭问卷筛查会遗漏重要共病,且未遵循AUA指南却获多数正面报道。
要点
- 年轻ED男性中代谢与性腺异常高发,DTC平台仅凭问卷无法识别。
- 精液分析异常率达40%,提示DTC模式可能延误生育评估。
- 多数新闻报道正面呈现DTC平台,可能误导患者高估其医疗评估充分性。
核心结论
- DTC互联网处方平台仅用问卷筛查,会遗漏年轻ED男性中显著的共病与病理发现。
- DTC平台未遵循AUA指南却以医疗权威自居,且获得多数正面媒体报道。
研究设计与样本
- 回顾性 review 了2016年1月至2019年3月在男科门诊评估的所有≤40岁ED男性,共388例。
- 分析5家新闻来源在研究期间对DTC平台的报道倾向(正面、批评或平衡/中立)。
主要发现
- 388例患者年龄29.5±5.0岁,肥胖率15%,糖尿病前期或糖尿病20%,血脂异常54%,性腺功能减退20%。
- 不育相关血清实验室异常占11%;64例接受精液分析者中40%异常;精索静脉曲张发现率35%。
- 328例(88%)处方PDE-5抑制剂;超说明书经验性治疗包括克罗米芬32.9%、芳香化酶抑制剂12.1%;9.7%启动睾酮替代。
- 新闻分析共18篇文章,其中61%对DTC平台完全持正面态度。
关键数值与推荐
- DTC平台仅使用问卷进行健康筛查,未遵循AUA指南。
- 诊室评估发现肥胖15%、糖尿病前期或糖尿病20%、血脂异常54%、性腺功能减退20%、不育相关实验室异常11%、精液分析异常40%、精索静脉曲张35%。
临床怎么用
- 对年轻ED患者应进行面对面评估,包括代谢、性腺及生育相关检查,而非仅依赖问卷。
- 泌尿科医生可整合远程医疗,为年轻男性提供循证评估以弥补DTC平台的不足。
局限性
- 单中心男科门诊的回顾性 review,样本为≤40岁ED男性,结果外推需谨慎。
- 新闻媒体分析仅纳入5家来源共18篇文章,代表性有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine comorbidities in young men with erectile dysfunction (ED) who are increasingly targeted by direct-to-consumer (DTC) internet platforms that sell phosphodiesterase-5 (PDE-5) inhibitors without comprehensive clinical evaluation; and, further, to characterize the portrayal of DTC platforms by popular news media. METHODS: We retrospectively reviewed all men age ≤40 evaluated for ED at an andrology clinic during January 2016-March 2019 to obtain demographics, exam and lab findings, and treatments. Five news sources were analyzed during the study period to characterize whether articles about DTC platforms were positive, critical, or balanced/neutral. RESULTS: We identified 388 patients, with age 29.5 ± 5.0 years, 15% rate of obesity, 20% prediabetes or diabetes, 54% dyslipidemia, and 20% hypogonadism. Serum lab findings associated with subfertility were found in 11%. Semen analysis was conducted in 64 men, of whom 40% were abnormal. Varicoceles were found in 35%. PDE-5 inhibitor was prescribed to 328 men (88%). Off-label empiric therapies included clomiphene (32.9%) or aromatase inhibitor (12.1%). Testosterone replacement was initiated in 9.7%. Analysis of news coverage revealed 18 articles, of which 61% portrayed DTC platforms exclusively in a positive light. CONCLUSION: Office consultation identified young men with significant comorbidities that would be missed by DTC platforms, which employ only questionnaires for health screening. DTC platforms present themselves as medical authorities without following AUA Guidelines, yet garner mostly positive press coverage. Patients engaging these platforms may falsely believe they are receiving adequate medical assessment. Urologists may do well to incorporate telemedicine to enfranchise young men with evidence-based evaluation.
引用
- Shahinyan RH, Amighi A, Carey AN, et al. Direct-To-Consumer Internet Prescription Platforms Overlook Crucial Pathology Found During Traditional Office Evaluation of Young Men With Erectile Dysfunction. Urology. 2020. PMID: 32535075. doi:10.1016/j.urology.2020.03.067
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。